Gastroesophageal reflux disease and Barrett’s esophagus

Introduction

Once again, the past year has seen the publication of numerous new papers in the fields of gastroesophageal reflux disease (GERD) and Barrett’s esophagus. From these papers we want to focus on six relevant studies that reflect the most interesting topics in the field.

References

• 1 Pandolfino J, Richer J, Ours T. et al . Ambulatory esophageal pH-monitoring using a wireless system.  Am J Gastroenterol. 2003;  98 740-749
• 2 Bruley des Varannes S, Mion F, Ducrotté P. et al . Simultaneous recordings of oesophageal acid exposure with conventional pH monitoring and a wireless system (Bravo).  Gut. 2005;  54 1682-1686
• 3 Pandolfino J, Zhang Q, Schreiner M. et al . Acid reflux event detection using the Bravo wireless versus the Slimline catheter ph systems: why are the numbers so different?.  Gut. 2005;  54 1687-1692
• 4 Wong W, Bautista J, Dekel R. et al . Feasibility and tolerability of transnasal/per-oral placement of the wireless pH capsule vs. traditional 24-h oesophageal pH monitoring-a randomized trial.  Aliment Pharmacol Ther. 2005;  21 155-163
• 5 Prakash C, Clouse R. Value of extended recording time with wireless pH monitoring in evaluating gastroesophageal reflux disease.  Clin Gastroenterol Hepatol. 2005;  3 329-334
• 6 Vaezi M, Hicks D, Abelson T. et al . Laryngeal signs and symptoms and gastroesophageal reflux disease (GERD): a critical assessment of cause and effect association.  Clin Gastroenterol Hepatol. 2003;  1 333-344
• 7 Spechler S. Laryngopharyngeal reflux: A cause of faulty phonation or a faulted phony diagnosis?.  Clin Gastroenterol Hepatol. 2006;  4 431-432
• 8 Eherer A, Habermann W, Hammer H. Effect of pantoprazole on the course of reflux-associated laryngitis: a placebo-controlled double-blind crossover study.  Scand J Gastroenterol. 2003;  38 462-467
• 9 Swoger J, Ponsky J, Hicks D. et al . Surgical fundoplication in laryngopharyngeal relux unresponsive to aggressive acid suppression: a controlled study.  Clin Gastroenterol Hepatol. 2006;  4 433-441
• 10 Westcott C, Hopkins M, Bach K. et al . Fundoplication for laryngopharyngeal reflux disease.  J Am Coll Surg. 2004;  199 23-30
• 11 Bittinger M. Messmann H. New endoscopic therapies for gastroesophageal reflux disease [in German].  Z Gastroenterol. 2003;  41 921-928
• 12 Shaheen N. The rise and fall (and rise?) of endoscopic anti-reflux procedures.  Gastroenterology. 2006;  131 952-954
• 13 Rothstein R, Filipi C, Caca K. et al . Endoscopic full-thickness plication for the treatment of gastroesophageal reflux disease: A randomized sham-controlled trial.  Gastroenterology. 2006;  131 704-712
• 14 Pleskow D, Rothstein R, Lo S. et al . Endoscopic full-thickness plication for the treatment of GERD: 12-month follow-up for the North American open-label trial.  Gastrointest Endosc. 2005;  61 643-649
• 15 Lagergren J. Adenocarcinoma of the oesophagus: What exactly is the size of the problem and who is at risk?.  GUT. 2005;  54 (Suppl I) I1-I5
• 16 Murray L, Watson P, Johnston B. et al . Risk of adenocarcinoma in Barrett’s oesophagus: population based study.  BMJ. 2003;  327 534-535
• 17 Solaymani-Dodaran M, Logan R, West J, Card T. Mortality associated with Barrett’s esophagus and gastroesophageal reflux disease diagnoses - a population-based cohort study.  Am J Gastroenterol. 2005;  100 2616-2621
• 18 Anderson L, Murray L, Murphy S. et al . Mortality in Barrett’s oesophagus: Results from a population based study.  GUT. 2003;  52 1081-1084
• 19 Eckardt V, Kanzler G, Bernhard G. Life expectancy and cancer risk in patients with Barrett’s esophagus: A prospective controlled investigation.  Am J Med. 2001;  111 33-37
• 20 Sampliner R. Updates guidelines for the diagnosis, surveillance, and therapy of Barrett’s esophagus.  Am J Gastroenterol. 2002;  97 1888-1895
• 21 Kara M, Bergman J. Autofluorescence imaging and narrow-band imaging for the detetction of early neoplasia in patients with Barrett’s esophagus.  Endoscopy. 2006;  38 627-631
• 22 Kara M, Peters F, Rosmolen W. et al . High-resolution endoscopy plus chromoendoscopy or narrow-band imaging in Barrett’s esophagus: a prospective crossover study.  Endoscopy. 2005;  37 929-936
• 23 Kara M. Peters F, Fockens P, et al. Endoscopic video-autofluorescence imaging followed by narrow band imaging for detecting early neoplasia in Barrett’s esophagus.  Gastrointest Endosc. 2006;  64 176-185
• 24 Weston A. Can deep freezing join the endoscopic Barrett’s mucosal ablation party? Cautious optimism is warranted.  Gastrointest Endosc. 2005;  62 849-852
• 25 Sampliner R. Endoscopic ablative therapy for Barrett’s esophagus: current status.  Gastrointest Endosc. 2004;  59 66-69
• 26 Johnston M, Eastone J, Horwat J. et al . Cryoablation of Barrett’s esophagus: a pilot study.  Gastrointest Endosc. 2005;  62 842-848
• 27 Overholt B, Lightdale C, Wang K. et al . Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett’s esophagus: international, partially blinded, randomized phase III trial.  Gastrointest Endosc. 2005;  62 488-498